Becker's Healthcare February 28, 2024
One of R1 RCM’s largest shareholders is asking the revenue cycle management company’s board to reject a potential offer to take the firm private.
Private equity firm Coliseum Capital Management, one of R1’s five largest shareholders, said in a Feb. 26 open letter that the proposed transaction “meaningfully undervalues the company and is not in the best interest of shareholders.”
Private equity firm New Mountain Capital and TCP-ASC — an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance — have been in talks regarding a number of options for R1 RCM, including a potential cash offer of $13.75 per share for R1’s outstanding stock. New Mountain owns 32.4% of R1 and TowerBrook owns 29.6%....
Today's Sponsors
Today's Sponsor